Is nanotechnology ready for primetime?
Brower
Vicki
V
D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage*; D050091:Dendrimers / Q000737:chemistry / Q000494:pharmacology; D004337:Drug Carriers / Q000737:chemistry / Q000494:pharmacology; D006801:Humans; D050997:Nanomedicine / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D049329:Nanostructures / Q000009:adverse effects; D036103:Nanotechnology / Q000191:economics / Q000331:legislation & jurisprudence / Q000639:trends; D009316:National Institutes of Health (U.S.); D009369:Neoplasms / Q000188:drug therapy* / Q000191:economics; D012109:Research Support as Topic; D014481:United States
D000970:Antineoplastic Agents; D050091:Dendrimers; D004337:Drug Carriers